GlassScriptPhysician profile
Wesley S Moore
NPI 1053335133
$31,577.91
in general payments reported to CMS, 2019-2025
10 companies · $506 in 2025
The $506 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $142 · 2021: $73.03 · 2022: $7,909 · 2023: $594 · 2024: $5,474 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,000 · Food and Beverage: $2,259 · Travel and Lodging: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,000.00 |
| Food and Beverage | $2,259.27 |
| Travel and Lodging | $315.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $28,854.27 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| W. L. Gore & Associates, INC. | $1,356.39 | 2019-2025 | Gore Excluder Aaa Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Gore Tag Thoracic Branch Endoprosthesis |
| Medtronic, INC. | $609.82 | 2023-2025 | Endurant Iis, Valiant Captivia |
| Cook Medical LLC | $208.26 | 2019-2024 | Zenith Alpha, Icast Covered Stent System, 6mmx22mmx120cm |
| Abbott Laboratories | $165.94 | 2023 | Perclose Proglide |
| Smith+Nephew, INC. | $124.34 | 2019 | |
| Endologix LLC | $102.52 | 2025 | Endocross Device, Torus Stent Graft System |
| Penumbra, INC. | $78.06 | 2024 | Indigo System |
| Baxter Healthcare | $58.39 | 2024 | Preveleak |
| Inspiremd LTD | $19.92 | 2025 | Cguard Prime Carotid Stent System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.